Chemodiversity and Biotechnological Potential of Microginins.

Joaquim da Silva Pinto Neto, Gustavo Marques Serra, Luciana Pereira Xavier, Agenor Valadares Santos

Abstract readReview

In one paragraph

Review in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

Secondary metabolism ofApplied and environmental microbiology · 2026
Review

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Joaquim da Silva Pinto NetoLaboratory of Biotechnology of Enzymes and Biotransformation, Biological Sciences Institute, Federal University of Pará, Belém 66075-110, PA, Brazil.ORCID 0000-0002-8599-5152

Gustavo Marques SerraLaboratory of Biotechnology of Enzymes and Biotransformation, Biological Sciences Institute, Federal University of Pará, Belém 66075-110, PA, Brazil.ORCID 0000-0002-5231-4453

Luciana Pereira XavierLaboratory of Biotechnology of Enzymes and Biotransformation, Biological Sciences Institute, Federal University of Pará, Belém 66075-110, PA, Brazil.ORCID 0000-0002-0913-8765

Agenor Valadares SantosLaboratory of Biotechnology of Enzymes and Biotransformation, Biological Sciences Institute, Federal University of Pará, Belém 66075-110, PA, Brazil.

Funding

National Council for Scientific and Technological Development 001PROPESP/UFPA 001

6 · The paper itself

Abstract

Biotechnology has increasingly focused on cyanobacteria as these microorganisms are a rich source of secondary metabolites with significant potential for various industries. Cyanobacterial metabolites have been described to have a wide range of biological activities, including cytotoxicity in cancer cells, inhibition of pathogenic bacteria and fungi, and inhibition of various enzymes, demonstrating a great diversity of bioactive compounds. The cyanobacterium

Indexed as

Bacterial ProteinsBiotechnologyAnimalsCyanobacteriaHumansMicrocystisBacterial Proteinsbiotechnologychemodiversitycyanobacteriamicrogininpeptide

Identifiers

PMID40649895

DOI10.3390/ijms26136117

PMCPMC12250027

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.